Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M162,815Revenue (TTM) $M39,385Net Margin (%)11.7Altman Z-Score3.2
Enterprise Value $M175,736EPS (TTM) $1.6Operating Margin %18.4Piotroski F-Score7
P/E(ttm)36.3Beneish M-Score-2.8Pre-tax Margin (%)14.3Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %3.8Quick Ratio1.4Cash flow > EarningsY
Price/Sales4.35-y EBITDA Growth Rate %9.2Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow15.2y-y EBITDA Growth Rate %-45.4ROA % (ttm)4.5Higher Current Ratio y-yY
Dividend Yield %3.1PEG4.0ROE % (ttm)10.1Less Shares Outstanding y-yY
Payout Ratio %112Shares Outstanding M2,768ROIC % (ttm)10.6Gross Margin Increase y-yY

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKT Rowe Price Equity Income Fund 2016-06-30 Reduce-0.3%$52.91 - $57.68
($55.73)
$ 58.826%Reduce -25.58%3,500,000
MRKRichard Pzena 2016-03-31 Buy 0.3%$48.59 - $53.32
($51.31)
$ 58.8215%New holding921,365
MRKJoel Greenblatt 2016-03-31 Add0.29%$48.59 - $53.32
($51.31)
$ 58.8215%Add 65.71%1,248,557
MRKKahn Brothers 2016-03-31 Reduce-0.24%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -2.52%985,419
MRKT Rowe Price Equity Income Fund 2016-03-31 Reduce-0.22%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -16.17%4,702,900
MRKVanguard Health Care Fund 2016-03-31 Reduce-0.18%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -3.46%48,728,100
MRKNWQ Managers 2016-03-31 Sold Out -0.06%$48.59 - $53.32
($51.31)
$ 58.8215%Sold Out0
MRKCharles Brandes 2016-03-31 Reduce-0.01%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -0.42%3,000,058
MRKKen Fisher 2016-03-31 Reduce-0.01%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -1.82%6,698,235
MRKMario Gabelli 2016-03-31 Reduce-0.01%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -15.38%118,145
MRKFirst Eagle Investment 2016-03-31 Add$48.59 - $53.32
($51.31)
$ 58.8215%Add 106.55%16,090
MRKBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Add$48.59 - $53.32
($51.31)
$ 58.8215%Add 0.03%26,663,511
MRKDavid Dreman 2016-03-31 Buy $48.59 - $53.32
($51.31)
$ 58.8215%New holding710
MRKDodge & Cox 2016-03-31 Reduce$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -0.08%24,543,704
MRKRuane Cunniff 2016-03-31 Reduce$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -2.00%4,894
MRKJoel Greenblatt 2015-12-31 Add0.43%$49.47 - $55.53
($52.9)
$ 58.8211%Add 12793.07%753,471
MRKT Rowe Price Equity Income Fund 2015-12-31 Reduce-0.21%$49.47 - $55.53
($52.89)
$ 58.8211%Reduce -14.63%5,610,000
MRKCharles Brandes 2015-12-31 Add0.17%$49.47 - $55.53
($52.9)
$ 58.8211%Add 7.90%3,012,572
MRKBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Add0.12%$49.47 - $55.53
($52.9)
$ 58.8211%Add 5.86%26,655,176
MRKVanguard Health Care Fund 2015-12-31 Add0.08%$49.47 - $55.53
($52.9)
$ 58.8211%Add 1.47%50,476,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GRADDICK WEIR MIRIAN MExe V-P, HR 2016-07-05Sell45,000$57.991.43view
FRAZIER KENNETH CChairman, President & CEO 2016-07-05Sell60,000$581.41view
Schechter Adam HEVP & Pres-Global Human Health 2016-07-01Sell50,000$57.691.96view
GRADDICK WEIR MIRIAN MExe V-P, HR 2016-07-01Sell30,000$57.492.31view
Golestani ClarkEVP & Chief Info Officer 2016-05-20Sell39,877$54.797.36view
Holston Michael JEVP, General Counsel 2016-05-10Sell100,021$54.57.93view
FRAZIER KENNETH CChairman, President & CEO 2016-04-14Sell131,040$56.114.83view
WEEKS WENDELL PDirector 2015-11-04Sell5,000$55.535.92view
AMBROSE ADELE DSr.V-P & Chief Comuns Officer 2015-10-29Sell37,313$55.086.79view
FRAZIER KENNETH CChairman, President & CEO 2015-10-29Sell18,666$54.697.55view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

News about MRK:

Articles On GuruFocus.com
T. Rowe Price Equity Income Fund Sells Apache, Johnson & Johnson in 2nd Quarter Jul 21 2016 
Technology Earnings Helping Market to Gain Jul 20 2016 
An Unfair Valuation Makes a Great Investment Jul 15 2016 
5 Overvalued Dow Components Jul 15 2016 
Stocks Higher After Release of FOMC Minutes Jul 07 2016 
Merck CEO Sells 60,000 Company Shares Jul 06 2016 
Market Indexes Higher With Volatility Lower May 25 2016 
The PBM Empire Strikes Back May 10 2016 
U.S. Stocks Trade Flat at Start of Week May 09 2016 
Market Indexes Flat as Economic Indicators Still Point Lower May 08 2016 

More From Other Websites
7:03 am Merck announces data in previously untreated adults with HIV-1 infection for the company's... Jul 23 2016
5 Big Drugmakers Reporting Earnings Next Week Jul 22 2016
Eli Lilly, J&J, Novo Battle Diabetes -- And Each Other Jul 22 2016
Merck Presents Data On Its Investigational Once-Daily Formulation Of ISENTRESS Jul 22 2016
Market Exclusive’s Inside the FDA: This Week Bezlotoxumab from Merck & Co., Inc. (MRK) Jul 22 2016
Data for Merck's Investigational Once-Daily Formulation of ISENTRESS® (raltegravir) Show That at... Jul 22 2016
Data for Merck's Investigational Once-Daily Formulation of ISENTRESS® (raltegravir) Show That at... Jul 22 2016
More Than 400 Women Are Now Suing Merck for Unequal Pay Jul 21 2016
Merck Animal Health Receives FDA Approval of BRAVECTO® (fluralaner topical solution) for Cats and... Jul 21 2016
Merck Provides Regulatory Update on Biologics Licensing Application for Investigational Agent... Jul 21 2016
These 5 Big Stocks Are Breaking Out This Summer Jul 21 2016
Six Major Biotech Acquisitions You Could See In 2016 (Part 1) Jul 20 2016
U.S. healthcare stock bulls look past political risks Jul 20 2016
What's behind heavy put volume in Merck Jul 20 2016
Merck & Co., Inc. (MRK) and OpGen Inc (OPGN) Are Quietly Changing The Infectious Disease Landscape Jul 19 2016
Why a Trump Win Could Be Good News for Pfizer, IBM Jul 19 2016
Merck KGaA's Multiple Sclerosis Drug under Review in EU Jul 19 2016
Here's When You Should Buy Merck Jul 18 2016
Analyst: Merck's Fundamentals Don't Warrant Current Valuation Jul 18 2016
Merck Receives European Medicines Agency Acceptance for Review of Marketing Authorization... Jul 18 2016
Dietmar Eidens Appointed Chief HR Officer (CHRO) of Merck Jul 15 2016
UK charity pockets $150 million from Merck cancer immunotherapy drug Jul 14 2016
Merck Advances Water Purification Systems with New High-Throughput Line Jul 13 2016
Merck Expands Excipients Portfolio, Adding Polymers for Sustained Release Injectables Jul 12 2016
Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as... Jul 06 2016
Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian... Jul 06 2016
Merck Commits €1.5 million to the Grant for Fertility Innovation (GFI) for 2016/17 Jul 06 2016
Juniper Pharmaceuticals Announces that Merck KGaA, Darmstadt, Germany, has Obtained Regulatory... Jul 05 2016
Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health... Jul 01 2016
Merck and University of Nairobi to Start Medical Oncology Fellowship Program Jul 01 2016
Successful Cooperation Between Merck and Agrimer in Marine-Derived Dermocosmetic Active Ingredients Jul 01 2016
Merck and Premier Inc. Collaborate to Prevent Fractures for Osteoporosis Patients Jun 30 2016
Merck and Premier Inc. Collaborate to Prevent Fractures for Osteoporosis Patients Jun 30 2016
Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance Jun 30 2016
Merck Receives Frost & Sullivan Award for Meoxal® and Xirallic® NXT Lines Jun 29 2016
FDA approves first pill to treat all forms of hepatitis C Jun 28 2016
Merck Expands Industry-Leading Emprove® Program to Include Filtration and Single-Use Products Jun 28 2016
Merck to Develop Next-Generation Purification Processes with International Vaccine Institute Jun 28 2016
Merck Receives CHMP Positive Opinion for KEYTRUDA® (pembrolizumab) for the Treatment of Advanced... Jun 27 2016
Merck to Hold Second-Quarter 2016 Sales and Earnings Conference Call on July 29 Jun 24 2016
German pharma lobby says EU drug regulator must leave London Jun 24 2016
Cavium and Marathon Oil skid, while Kroger and Newmont rise Jun 16 2016
Merck to buy biotech drug developer Afferent Pharmaceuticals Jun 09 2016
Business Highlights May 05 2016
Merck beats 1Q profit views with tight cost controls May 05 2016
New tests for choosing right hep C drug could save money Apr 14 2016
A look at Bayer AG Apr 01 2016
Experts warn complacency on Ebola may leave vaccine work unfinished Mar 31 2016
Business Highlights Mar 25 2016
Jury: Gilead owes Merck $200M in damages over drug patents Mar 25 2016
Jury finds for Merck in hepatitis drug fight with Gilead Mar 22 2016
Asian markets mixed ahead of Fed decision, China meeting Mar 15 2016
Merck, Sanofi Pasteur ending JV to market vaccines in Europe Mar 08 2016
Merck, Sanofi Pasteur ending JV to market vaccines in Europe Mar 08 2016
Study: $3B will be wasted on unused portion of cancer drugs Mar 01 2016
Rivals chase Bristol-Myers in cancer immunotherapy drug race Feb 26 2016
Small study suggests ZMapp may boost Ebola virus survival Feb 24 2016
Merck KGaA says consumer health saw 'nice' growth in 2015 Feb 23 2016
UK watchdog fines GSK $54 mln over 'pay-for-delay' drug deals Feb 12 2016
FDA panel backs lower-cost version of J&J's top-selling drug Feb 09 2016
Merck beats 4Q profit forecast, misses Street view on sales Feb 03 2016
FDA OKs Merck hepatitis C drug, adding to patient choices Jan 28 2016
Gavi signs $5bn Ebola vaccine deal Jan 20 2016
Global Vaccine promises $5 million to develop Ebola vaccine Jan 20 2016
Fight over Merck name sees German firm win in British court Jan 15 2016
Merck Acquires IOmet Pharma and Expands Immuno-Oncology Development Program Jan 11 2016
Pfizer set to buy Allergan for more than $150 bln-sources Nov 22 2015
Ex-BNY Mellon employee sentenced to 6 months in U.S. prison Nov 12 2015
GSK heart drug flops in study, shingles vaccine on track Oct 27 2015
KEYTRUDA® (pembrolizumab) Receives New Draft Recommendation from National Institute for Health and... Oct 09 2015
BUZZ-Lilly shares add to gains after diabetes drug finding Sep 17 2015
UK backs use of Merck cancer immunotherapy after price discount Sep 07 2015
Only two Ebola cases reported in past week, but risks remain - WHO Aug 04 2015
After Merck success, work goes on with other Ebola vaccines Jul 31 2015
Cancer immunomodulators market players Merck and Dynavax announce partnership for clinical trials Jun 16 2015
UPDATE 1-U.S. bird flu causes egg shortage, emergency measures May 23 2015
U.S. bird flu causes egg shortage, emergency measures May 22 2015
U.S. bird flu causing egg squeeze, emergency measures May 22 2015
Supreme Court bars Glenmark from selling Merck drug copies May 15 2015
India caps prices of 52 more "essential" drugs - NPPA Dec 12 2014
Pfizer dampens Astra bid hopes with German Merck cancer deal Nov 17 2014
Germany's Merck to buy Sigma-Aldrich for $17 bln Sep 22 2014
Merck licenses experimental psoriasis drug to Sun Pharma Sep 17 2014
Merck KGaA agrees to market Lupin drugs in emerging countries Sep 16 2014
Merck aims to hike revenues in China to 1 bln eur by 2018 Jul 26 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)